- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06764901
Scalable Technology for Online Prevention of Child Sexual Abuse (CSA) and CSA Materials (STOP-CSAM)
Scalable Technology for Online Prevention of Child Sexual Abuse (CSA) and CSA Materials - a Randomized Controlled Trial
- Summary The STOP-CSAM Study is a two-armed randomized controlled trial of a non-pharmacological Therapy Chat Service for prevention of Child Sexual Abuse (CSA) and Child Sexual Abuse Materials (CSAM) in self-referred and self motivated patients with high frequent CSAM use and non-detected by the legal authorities.
- Trial design This study is a prospective multicentred, stratified, parallel-group superiority study conducted in Germany, Czechia and Spain.
- Background There has been a significant increase in child sexual abuse material (CSAM) on the internet in recent years. The use of CSAM is problematic especially because it creates a demand for and maintains contact child sexual abuse. Unfortunately, despite the significant increase in the number of CSAM users, limited resources are available for investigation and prosecution. Consequently, many users remain in the community, with neither intervention from the criminal justice system, nor the health system. The proposed study will examine whether a therapy chat service (TCS) intervention reduces the demand for, circulation and spread of CSAM in undetected offenders, as compared to a control group.
- Methods The sample consists of individuals aged 18 years or older (expected N = 630), who have used CSAM in the prior two weeks and are seeking help voluntarily. Participants will be randomized to (1) a Therapy Chat Service (TCS) intervention or (2) a four-week waitlist (control group) followed by a TCS intervention. The TCS intervention group will receive four to six one-hour online therapy chat sessions over the period of four weeks, while the control group will remain on a waitlist for these four weeks before receiving the same TCS intervention. Assessments will be conducted at baseline (pre-intervention) and at 4-, 8-, 12- and 16-weeks post-intervention. The main objective of the study is to compare the effectiveness of TCS in the prevention of CSAM use within a sample of self-referred participants. The primary outcome is the significant decrease of CSAM consumption, which will be assessed by comparing self-reported severity and time spent using CSAM in the two weeks before the intervention and at four weeks following the intervention. Potential progress measures include time spent, severity and frequency of CSAM consumed. Psychological wellbeing and total sexual outlet will be also measured as secondary outcomes, other participant variables such as risk factors for CSAM consumption or sexual interests and therapeutic variables such as number of patient-therapist interactions, modules covered per session, common factors of psychotherapy, adverse effects of intervention and dropout rate will be also measured. Outcomes between groups will be compared following standard principles for RCTs.
- Results The study will open for recruitment in October 2023, and data collection is expected to be completed by November 2024. The results for the primary outcomes are planned to be analysed by December 2024 and submitted for publication by the end of the project in March 2025.
- Discussion The study will test whether the TCS intervention has a positive effect, not only in terms of reducing self-seeking potential sexual offenders' problematic sexual behaviours, but also on measures such as psychological wellbeing in CSAM users. Possible adverse effects of TCS intervention will also be assessed.
Recently, a similar trial called PRIOTAB-CBT, compared pre- and post-treatment outcome measures between a treatment group to a control group (Lätth et al., 2022). Results showed a significantly larger reduction in time spent using CSAM in the treatment group, in comparison to the control group. PRIOTAB-CBTh was a single-centre, single-blinded, psychological placebo-controlled RCT of an online cognitive behavioural psychotherapy. If the STOP-CSAM trial demonstrates that a TCS intervention reduces CSAM use, it could be an effective prevention strategy for sexual violence against children.
8. Funding European Commission - Internal Security Fund (ISF-2021).
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adult participant (≥18 years);
- use of CSAM in the previous 2 weeks;
- English, German, Czech, Spanish or Portuguese speaker;
- voluntary participation and agreement with the terms of the study.
Exclusion Criteria:
- Having severe neuropsychiatric comorbidities (unstable psychotic disorder, organic brain damage, diminished intellectual capabilities, untreated drug or alcohol addiction);
- current inpatient psychiatric stays and/or any other current treatment for CSAM behaviour;
- CSA perpetration history (past or present);
- currently under a criminal investigation, proceeding, punishment or probation status for committing online or offline CSA or CSAM use
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Waitlist
Control group: Waitlist.
|
|
|
Experimental: TCS Intervention
|
Online Therapy Chat Service (TCS) based on CBT techniques from the Berlin Dissexuality Therapy (Beier, K. M. (2021).
Pedophilia, hebephilia and sexual offending against children.
The Berlin Dissexuality Therapy (BEDIT).
Springer).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
proportion of patients with a reduction in the severity or duration of CSAM use
Time Frame: At the end of waiting period and/or intervention, usually 4 to 6 weeks after onboarding and following up every two weeks up to 16 weeks after onboarding
|
|
At the end of waiting period and/or intervention, usually 4 to 6 weeks after onboarding and following up every two weeks up to 16 weeks after onboarding
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Frequency of CSAM consumption (self-reported)
Time Frame: every 2 weeks for 16 weeks after onboarding
|
How often have you used these materials during the last two weeks?
|
every 2 weeks for 16 weeks after onboarding
|
|
Increased mental wellbeing (composite)
Time Frame: comparing week 1 and week 4
|
Dichotomous outcome defined by an increase of a 10% or greater in mental wellbeing o Mental wellbeing (self-reported): ● Measured with the Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS; Tennant et al., 2007). |
comparing week 1 and week 4
|
|
Total sexual outlet (self-reported)
Time Frame: every 2 weeks for 16 weeks after onboarding
|
|
every 2 weeks for 16 weeks after onboarding
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 8000186001
- 101084719 (Other Grant/Funding Number: European Commission - Internal Security Fund (ISF-2021))
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sexual Behavior
-
Universitat Jaume IMinisterio de Ciencia e Innovación, SpainCompletedSexual Compulsive Behavior Disorder | Cybersex Addiction | Online Compulsive Sexual BehaviorSpain
-
Universitat Jaume ICompletedSexual Compulsive Behavior Disorder | Cybersex Addiction | Online Compulsive Sexual BehaviorSpain
-
Medstar Health Research InstituteSHE FoundationCompletedSexual Behavior | Sexual ActivityUnited States
-
Radicle ScienceCompletedSexual Function | Sexual SatisfactionUnited States
-
Universidad Europea de MadridApoyo PositivoCompletedHypersexuality | Compulsive Sexual Behavior | Sexualized Drug Use (Chemsex)Spain
-
Université de Reims Champagne-ArdenneCompletedSexual IntercourseFrance
-
Children's Mercy Hospital Kansas CityEnrolling by invitationEvaluating the Impact of CHOICE-AYA on Contraceptive Use, Continuation and Satisfaction (CHOICE-AYA)Sexual Behavior | Contraception Behavior | Reproductive BehaviorUnited States
-
Child TrendsUniversity of California, San Francisco; Power to DecideRecruiting
-
Montana State UniversityNational Institute on Minority Health and Health Disparities (NIMHD); Northern... and other collaboratorsCompletedSexual Behavior | Reproductive BehaviorUnited States
-
University of California, San DiegoCenters for Disease Control and Prevention; California Department of Public...Enrolling by invitationSexual Violence | Adolescent Behavior | Sexual AssaultUnited States
Clinical Trials on Online Therapy Chat Service (TCS)
-
Charite University, Berlin, GermanyUniversitat Internacional de CatalunyaRecruitingSexual Behavior | Behavior Problems | Prevention | Behavioral Disorder | Well Being | Behavior Change | Behavior Change Interventions | Child Sexual Abuse Material (CSAM) Consumption | Online BehaviourGermany, Spain
-
Oslo University HospitalUniversity of Oslo; Columbia University; University Hospital of North Norway; Marshfield... and other collaboratorsCompleted
-
University of JyvaskylaAcademy of FinlandCompleted
-
KTO Karatay UniversityCompleted
-
Icahn School of Medicine at Mount SinaiNational Institute for Occupational Safety and Health (NIOSH/CDC)CompletedPost-Traumatic Stress DisorderUnited States
-
University of California, DavisCompleted
-
University of Southern DenmarkIrish Research Council; Academisch Medisch Centrum - Universiteit van Amsterdam... and other collaboratorsUnknown
-
University of Colorado, DenverThe Leona M. and Harry B. Helmsley Charitable TrustCompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1 | Continuous Glucose MonitoringUnited States
-
University of California, DavisCompletedAtopic DermatitisUnited States
-
City University of Hong KongNot yet recruiting